Measurement of Sarcopenia in Head and Neck Cancer Patients and Its Association With Frailty

Measurement of Sarcopenia in Head and Neck Cancer Patients and Its Association With Frailty

In head and neck cancer (HNC) there is a need for more personalized treatment based on risk assessment for treatment related adverse events (i.e. toxicities and complications), expected survival and quality of life. Sarcopenia, defined as a condition characterized by loss of skeletal muscle mass and...

Full description

Bibliographic Details
Main Authors: Remco de Bree, Christiaan D. A. Meerkerk, Gyorgy B. Halmos, Antti A. Mäkitie, Akihiro Homma, Juan P. Rodrigo, Fernando López, Robert P. Takes, Jan B. Vermorken, Alfio Ferlito
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
head and neck cancer
elderly
sarcopenia
skeletal muscle mass
frailty
toxicity
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.884988/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.884988/full

Similar Items